Lonza: Data Integrity for Endotoxin Testing

Data Integrity for Endotoxin Testing – New FAQs Released to the QC Insider™ Toolbox

 

Walkersville, MD (USA) / Cologne (DE), 20 July 2017 – Today Lonza announced the release of a new FAQ Tech Tip, “Data Integrity for Endotoxin Testing” for its QC Insider™ Toolbox. Since data integrity is a fundamental component of the pharmaceutical industry, this new support tool will assist QC professionals who are performing bacterial endotoxin testing.

 

Data integrity is the degree to which a collection of data is complete, consistent and accurate throughout the data lifecycle and is an essential requirement by regulatory authorities. The new FAQ Tech Tip provides a detailed description of data integrity, its requirements and what they mean, as well as guidance for ensuring compliance in endotoxin testing.

 

Katrin Hoeck, Head of Marketing Analysis and Testing at Lonza Bioscience Solutions explains: “For QC professionals, it is important to ensure data integrity is implemented throughout their endotoxin testing processes. Our new FAQ Tech Tip not only addresses the basic principles of data integrity, but also provides an in-depth look at the advantages of using a quantitative endotoxin detection system and describes how our WinKQCL™ Software can help meet data integrity requirements.”

 

Launched in 2015 the QC Insider™ Toolbox is an online suite of comprehensive tools designed to help QC professionals conduct the bacterial endotoxins test (BET). It offers a variety of self-directed training resources, support materials and a library of technical information to help ensure success with endotoxin testing.

 

Registration for the QC Insider™ Toolbox is free and can be accessed at: www.lonza.com/qcinsider. (Special use terms will apply.)

 

About Lonza

Following the closing of the Capsugel acquisition, Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

 

An integrated solutions provider serving the healthcare continuum, Lonza offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. In addition to drinking water sanitizers, nutraceuticals, antidandruff agents and other personal care ingredients, the company provides agricultural products, advanced coatings and composites and microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

 

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 50 major manufacturing and R&D facilities and nearly 14,000 full-time employees worldwide. Further information can be found at www.lonza.com.

 

Lonza Contact Information

Lonza Cologne GmbH

Manager Marketing Communications

Petra Haberkamm

Tel +49 221 991990

petra.haberkamm@lonza.com

 

Lonza Group Ltd

Head External Communications

Constance Ward

Tel +41 61 316 8840

constance.ward@lonza.com

 

Additional Information and Disclaimer

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

 

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.